In a major move against high prescription costs, AstraZeneca has agreed to sell its drugs at a discount through Medicaid, marking a significant win for the Trump administration's healthcare initiative.
President Trump reveals plans for a new website, TrumpRx, aimed at providing discounted prescription medications directly to Americans, particularly benefiting low-income families. This initiative follows Pfizer's agreement to lower drug prices, promising a transformative approach to healthcare access.
President Trump announces a controversial 100% tariff on foreign brand-name drugs, leaving patients and experts questioning the implications for prescription prices and U.S. manufacturing. Will your medications cost more?
In a bold move, the Trump administration is sending out 100 cease-and-desist letters to drug companies, aiming to eliminate misleading ads. This crackdown includes increased transparency about drug risks and closing loopholes that conceal vital safety information.
In a groundbreaking move, President Trump has signed a memorandum urging pharmaceutical companies to adhere to transparency laws in their advertising, especially on social media. This initiative aims to ensure accurate drug information and tackle misleading ads, marking a significant shift in health policy.
In a landmark decision, the Trump administration vows to overhaul the regulations on prescription drug advertising. This move aims to ensure consumers receive accurate information about the risks and benefits of medications, combatting misleading ads that favor expensive drugs over affordable generics.
The White House is set to fix errors in Secretary Kennedy's 'Make America Healthy Again' report, which faced scrutiny for citing studies that don’t exist. Despite controversies, the report aims to transform public health policy.
In a bold move, President Trump is set to sign an executive order mandating the U.S. health department to negotiate lower drug prices with pharmaceutical companies. This could drastically change healthcare costs for millions of Americans.
In a groundbreaking move, President Trump has issued an executive order aimed at ending the price discrimination faced by American consumers in the pharmaceutical market. This order seeks to ensure that Americans pay the same low prices for medications as those in other developed nations, addressing the long-standing issue of subsidizing global pharmaceutical profits.
In a landmark move, President Trump signs an Executive Order aimed at reducing prescription drug prices for Americans, aligning them with those in other wealthy nations. This initiative seeks to curb unfair pricing practices and ensure a fair deal for U.S. patients.
